Analyst Ratings for Neogenomics (NEO)
NEO Rating Summary
NEO Price Target Summary
- Highest: $25.00 (Leerink)
- Lowest: $11.00 (Stephens)
- Average: $14.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.60 (+5.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$14.60 (+5.1%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/29/2026 | Benchmark » Updated 7/24/2026 |
Bruce Jackson | Upgrade | Buy (Hold) |
16.00 (11.00) |
9.02 (13.89) |
53.99% | Details |
| 4/29/2026 | Leerink | Puneet Souda | Upgrade | Outperform (Market Perform) |
25.00 (N/A) |
9.02 (13.89) |
53.99% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
